HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Analgesic effect of epidural neostigmine after abdominal hysterectomy.

AbstractSTUDY OBJECTIVE:
To evaluate the effects of epidurally administered neostigmine on pain after abdominal hysterectomy.
DESIGN:
Prospective, randomized, double-blind study.
SETTING:
Teaching hospital.
PATIENTS:
45 ASA physical status I adult patients scheduled for abdominal hysterectomy.
INTERVENTIONS:
All patients received identical general and epidural anesthesia. At the end of the surgery, they received epidural bupivacaine (10 mg) with either saline (control group, n = 15), 5 micro g/kg (5-micro g group, n = 15), or 10 micro g/kg neostigmine (10-micro g group, n = 15). Postoperatively, 50 mg diclofenac suppository was given for pain relief on patient demand.
MEASUREMENTS AND MAIN RESULTS:
The time to first diclofenac administration and the number of times diclofenac was required during the first 24 postoperative hours were recorded. Pain was assessed using a 10-cm visual analog pain scale (VAS) at rest at the first diclofenac request, and at 15 and 24 hours after surgery. The time to first diclofenac administration was significantly longer (p < 0.05) in the 10-micro g group (223 +/- 15 min) than in the control (78 +/- 17 min) or 5-micro g groups (88 +/- 18 min). However, epidural neostigmine at both doses did not reduce the number of postoperative diclofenac administrations. There were no differences in VAS among the three groups.
CONCLUSIONS:
Epidural neostigmine of 10 micro g/kg in bupivacaine provides a longer duration of analgesia than does bupivacaine alone or with 5 micro g/kg of neostigmine after abdominal hysterectomy.
AuthorsM Nakayama, H Ichinose, K Nakabayashi, O Satoh, S Yamamoto, A Namiki
JournalJournal of clinical anesthesia (J Clin Anesth) Vol. 13 Issue 2 Pg. 86-9 (Mar 2001) ISSN: 0952-8180 [Print] United States
PMID11331165 (Publication Type: Clinical Trial, Journal Article, Randomized Controlled Trial)
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Cholinesterase Inhibitors
  • Diclofenac
  • Neostigmine
Topics
  • Analgesia, Epidural
  • Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)
  • Cholinesterase Inhibitors (adverse effects, therapeutic use)
  • Diclofenac (therapeutic use)
  • Double-Blind Method
  • Female
  • Humans
  • Hysterectomy
  • Male
  • Middle Aged
  • Neostigmine (adverse effects, therapeutic use)
  • Pain Measurement (drug effects)
  • Pain, Postoperative (drug therapy)
  • Preanesthetic Medication
  • Prospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: